Clinical approach to optic neuritis: Pitfalls, red flags and differential diagnosis

Therapeutic Advances in Neurological Disorders

Volumn 4, Issue 2, 2011, Pages 123-134

  Voss, Elke ^a   Raab, Peter ^a   Trebst, Corinna ^a   Stangel, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

differential diagnosis; multiple sclerosis; optic neuritis

Indexed keywords

AZATHIOPRINE; GADOLINIUM; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ADULT; ANAMNESIS; ARTHRALGIA; BLOOD EXAMINATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUMBAR PUNCTURE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; OPTIC NEURITIS; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

EID: 79956002350     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285611398702     Document Type: Review

References (60)

1. Avery G. Tang R.A. Close L.G. (1983) Ophthalmic manifestations of mucoceles. Ann Ophthalmol 15: 734–737.
2. Balcer L.J. (2006) Clinical practice. Optic neuritis. N Engl J Med 354: 1273–1280.
3. Barbera L.G. Weiss M.J. Hofeldt A.J. (1996) Diabetic retinopathy and diabetic papillopathy. Semin Neurol 16: 179–185.
4. Beck R.W. Cleary P.A. Anderson M.M. Jr Keltner J.L. Shults W.T. Kaufman D.I. et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326: 581–588.
5. Beck R.W. Gal R.L. Bhatti M.T. Brodsky M.C. Buckley E.G. Chrousos G.A. et al (2004) Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137: 77–83.
6. Bodaghi B. LeHoang P. (2000) Ocular tuberculosis. Curr Opin Ophthalmol 11: 443–448.
7. Brusaferri F. Candelise L. (2000) Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 247: 435–442.
8. Carroll S.C. Gaskin B.J. Danesh-Meyer H.V. (2006) Giant cell arteritis. Clin Experiment Ophthalmol 34: 159–173.
9. Chen Y.H. Wang A.G. Lin Y.C. Yen M.Y. (2008) Optic neuritis as the first manifestation of rheumatoid arthritis. J Neuroophthalmol 28: 237–238.
10. Cikes N. Bosnic D. Sentic M. (2008) Non-MS autoimmune demyelination. Clin Neurol Neurosurg 110: 905–912.
11. Comi G. Filippi M. Barkhof F. Durelli L. Edan G. Fernandez O. et al (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357: 1576–1582.
12. Cooper G.S. Bynum M.L. Somers E.C. (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33: 197–207.
13. de Seze J. Arndt C. Jeanjean L. Zephir H. Blanc F. Labauge P. et al (2008) Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology 70: 2075–2076.
14. Eddleman C.S. Liu J.K. (2007) Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus 23: E4–E4.
15. Fontal M.R. Kerrison J.B. Garcia R. Oria V. (2007) Ischemic optic neuropathy. Semin Neurol 27: 221–232.
16. Ghezzi A. Martinelli V. Rodegher M. Zaffaroni M. Comi G. (2000) The prognosis of idiopathic optic neuritis. Neurol Sci 21: S865–S869.
17. Graham E.M. Ellis C.J. Sanders M.D. McDonald W.I. (1986) Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry 49: 756–763.
18. Hernandez-Rodriguez J. Font C. Garcia-Martinez A. Espigol-Frigole G. Sanmarti R. Canete J.D. et al (2007) Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients. Medicine (Baltimore) 86: 233–241.
19. Hickman S.J. Dalton C.M. Miller D.H. Plant G.T. (2002) Management of acute optic neuritis. Lancet 360: 1953–1962.
20. Jindahra P. Hedges T.R. Mendoza-Santiesteban C.E. Plant G.T. (2010) Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol 23: 16–23.
21. Kang J.H. Chen Y.H. Lin H.C. (2010) Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol 17: 1215–1219.
22. Kansu T. Kadayifcilar S. (2006) Visual aspects of Behcet's disease. Curr Treat Options Neurol 8: 81–88.
23. Kappos L. Freedman M.S. Polman C.H. Edan G. Hartung H.P. Miller D.H. et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8: 987–997.
24. Karma A. Seppala I. Mikkila H. Kaakkola S. Viljanen M. Tarkkanen A. (1995) Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol 119: 127–135.
25. Kaufman D.I. Trobe J.D. Eggenberger E.R. Whitaker J.N. (2000) Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the quality standards subcommittee of the American Academy of Neurology. Am J Ophthalmol 130: 541–542.
26. Kerr N.M. Chew S.S. Danesh-Meyer H.V. (2009) Non-arteritic anterior ischaemic optic neuropathy: a review and update. J Clin Neurosci 16: 994–1000.
27. Kidd D. Burton B. Plant G.T. Graham E.M. (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126: 276–284.
28. Kupersmith M.J. Martin V. Heller G. Shah A. Mitnick H.J. (2004) Idiopathic hypertrophic pachymeningitis. Neurology 62: 686–694.
29. La Mantia L. Curone M. Rapoport A.M. Bussone G. (2006) Tolosa–Hunt syndrome: critical literature review based on IHS 2004 criteria. Cephalalgia 26: 772–781.
30. Lennon V.A. Wingerchuk D.M. Kryzer T.J. Pittock S.J. Lucchinetti C.F. Fujihara K. et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106–2112.
31. Li J. Tripathi R.C. Tripathi B.J. (2008) Drug-induced ocular disorders. Drug Saf 31: 127–141.
32. Lin Y.C. Wang A.G. Yen M.Y. (2009) Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol 87: 204–210.
33. Matiello M. Lennon V.A. Jacob A. Pittock S.J. Lucchinetti C.F. Wingerchuk D.M. et al (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70: 2197–2200.
34. McDonald W.I. Compston A. Edan G. Goodkin D. Hartung H.P. Lublin F.D. et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121–127.
35. Milea D. Amati-Bonneau P. Reynier P. Bonneau D. (2010) Genetically determined optic neuropathies. Curr Opin Neurol 23: 24–28.
36. Maggioni F. Ruffatti S. Viaro F. Mainardi F. Lisotto C. Zanchin G. (2007) A case of posterior scleritis: differential diagnosis of ocular pain. J Headache Pain 8: 123–126.
37. Monson D.M. Smith J.R. (2011) Acute zonal occult outer retinopathy. Surv Ophthalmol 56: 23–35.
38. Montagnac R. Nyandwi J. Loiselet G. Pradel J. Schillinger F. (2009) [Ophthalmic manifestations in Wegener's granulomatosis. Review of literature about an observation]. Nephrol Ther 5: 603–613.
39. Nilsson P. Larsson E.M. Maly-Sundgren P. Perfekt R. Sandberg-Wollheim M. (2005) Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol 252: 396–402.
40. Optic Neuritis Study Group. (1991) The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109: 1673–1678.
41. Optic Neuritis Study Group. (1997) The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 49: 1404–1413.
42. Orssaud C. Roche O. Dufier J.L. (2007) Nutritional optic neuropathies. J Neurol Sci 262: 158–164.
43. Palace J. Leite M.I. Nairne A. Vincent A. (2010) Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 67: 1016–1017.
44. Petzold A. (2008) Isolated, relapsing and progressive demyelinating diseases of the central nervous system. J Neurol 255(Suppl. 6): 69–76.
45. Pittock S.J. Lennon V.A. de Seze J. Vermersch P. Homburger H.A. Wingerchuk D.M. et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78–83.
46. Raps E.C. Rogers J.D. Galetta S.L. Solomon R.A. Lennihan L. Klebanoff L.M. et al (1993) The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol 50: 265–268.
47. Ray S. Gragoudas E. (2001) Neuroretinitis. Int Ophthalmol Clin 41: 83–102.
48. Rodriguez M. Siva A. Cross S.A. O'Brien P.C. Kurland L.T. (1995) Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45: 244–250.
49. Rothstein J. Maisel R.H. Berlinger N.T. Wirtschafter J.D. (1984) Relationship of optic neuritis to disease of the paranasal sinuses. Laryngoscope 94: 1501–1508.
50. Salvarani C. Cimino L. Macchioni P. Consonni D. Cantini F. Bajocchi G. et al (2005) Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 53: 293–297.
51. Sastre-Garriga J. Reverter J.C. Font J. Tintoré M. Espinosa G. Montalban X. (2001) Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 49: 408–411.
52. Sellner J. Boggild M. Clanet M. Hintzen R.Q. Illes Z. Montalban X. et al (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17: 1019–1032.
53. Shimizu J. Hatanaka Y. Hasegawa M. Iwata A. Sugimoto I. Date H. et al (2010) IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75: 1423–1427.
54. Tenembaum S. Chitnis T. Ness J. Hahn J.S. (2007) Acute disseminated encephalomyelitis. Neurology 68: S23–S36.
55. Theodoridou A. Settas L. (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77: 290–295.
56. Trebst C. Reising A. Kielstein J.T. Hafer C. Stangel M. (2009) Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 28: 108–115.
57. Tumani H. (2008) Corticosteroids and plasma exchange in multiple sclerosis. J Neurol 255(Suppl. 6): 36–42.
58. Vardizer Y. Tomkins O. Briscoe D. (2010) Clinical assessment of thyroid related orbitopathy: a review. Pediatr Endocrinol Rev 7(Suppl. 2): 186–192.
59. Wingerchuk D.M. Lennon V.A. Lucchinetti C.F. Pittock S.J. Weinshenker B.G. (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805–815.
60. Wingerchuk D.M. Lennon V.A. Pittock S.J. Lucchinetti C.F. Weinshenker B.G. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485–1489.